Wasn't expecting much from HHS. And they sure didn't deliver much ha. Ugly comp. But earnings maybe better than they appeared, as there was a severance charge in the quarter-
"Net income for the quarter was $0.6 million, or $0.08 per diluted share, compared to net income of $4.5 million, or $0.52 per diluted share, in the second quarter last year. Results this quarter included $1.2 million of pension expense, as well as $503,000 in stock-based compensation and $1.2 million in severance, largely related to the CEO transition. The severance and other costs related to the CEO transition created a non-recurring, $0.12 per share impact, without tax impact, in the second quarter of 2023."
I'm in no rush to buy in the $5's as the stock probably languishes. But I wouldn't short down here with their EPS power...in case the new guy does get things turned around.
Market Data 
Markets 
AI
